Stockscreener 앱 받기
8.935
4.53%
-0.445
전일 마감가:
$9.38
열려 있는:
$9.35
하루 거래량:
783.62K
Relative Volume:
0.57
시가총액:
$614.36M
수익:
$65,400
순이익/손실:
$-46.34M
주가수익비율:
-9.712
EPS:
-0.92
순현금흐름:
$-38.74M
1주 성능:
-1.16%
1개월 성능:
+52.82%
6개월 성능:
-11.77%
1년 성능:
+53.34%
1일 변동 폭
$8.86
$9.39
1주일 범위
$8.86
$9.82
52주 변동 폭
$3.61
$13.85
CorMedix Inc Stock (CRMD) Company Profile
명칭
CorMedix Inc
전화
908-517-9500
주소
400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ
CRMD을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CRMD
CorMedix Inc
|
8.91 | 614.36M | 65,400 | -46.34M | -38.74M | -0.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
502.60 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
605.07 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.39 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
269.33 | 32.98B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
254.48 | 26.89B | 3.81B | -644.79M | -669.77M | -6.24 |
CorMedix Inc Stock (CRMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-07 | 개시 | Leerink Partners | Outperform |
| 2025-01-13 | 개시 | D. Boral Capital | Buy |
| 2024-08-26 | 개시 | Rodman & Renshaw | Buy |
| 2023-08-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-02-17 | 개시 | Needham | Buy |
| 2020-09-29 | 개시 | JMP Securities | Mkt Outperform |
| 2020-09-21 | 개시 | Truist | Buy |
| 2019-12-18 | 개시 | B. Riley FBR | Buy |
| 2019-03-26 | 재확인 | H.C. Wainwright | Buy |
| 2018-12-06 | 개시 | ROTH Capital | Buy |
| 2017-09-25 | 재확인 | H.C. Wainwright | Buy |
| 2017-08-10 | 재확인 | Rodman & Renshaw | Buy |
| 2017-05-05 | 재확인 | Rodman & Renshaw | Buy |
| 2016-11-11 | 재확인 | FBR & Co. | Outperform |
| 2016-03-17 | 재확인 | FBR Capital | Outperform |
| 2016-03-03 | 개시 | FBR Capital | Outperform |
| 2015-11-16 | 재확인 | ROTH Capital | Neutral |
| 2015-10-29 | 재확인 | ROTH Capital | Neutral |
| 2015-05-06 | 다운그레이드 | ROTH Capital | Buy → Neutral |
| 2014-12-08 | 재확인 | ROTH Capital | Buy |
| 2011-10-03 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
CorMedix Inc 주식(CRMD)의 최신 뉴스
CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025 - The Globe and Mail
Market Momentum Report: CorMedix Inc (CRMD)’s Positive Close at 9.65 - DWinneX
Investors in cash trouble should check out CorMedix Inc (CRMD) - Sete News
The CorMedix Inc (CRMD) had a good session last reading, didn’t it? - uspostnews.com
Investing in CorMedix Inc (CRMD): What You Must Know - knoxdaily.com
CorMedix Inc. to Announce First Quarter 2025 Financial Results and Corporate Update on May 6, 2025 - Nasdaq
Cormedix To Report First Quarter 2025 Financial Results - marketscreener.com
CorMedix Q1 2025 Financial Results: How to Access the Latest Earnings Call May 6 - Stock Titan
Form DEFA14A CorMedix Inc. - StreetInsider
Press Release Distribution & PR Platform - ACCESS Newswire
CorMedix Inc: Navigating Market Volatility with a 1.79 Debt-to-Equity Ratio - investchronicle.com
Upward Trajectory: CorMedix Inc (CRMD) Posts a Gaine, Closing at 8.50 - DWinneX
CorMedix Inc (CRMD) may enjoy gains as insiders got busy in the recent days - knoxdaily.com
Perhaps timely catching CorMedix Inc (CRMD) would be a good idea - Sete News
Breakeven Is Near for CorMedix Inc. (NASDAQ:CRMD) - simplywall.st
Are CorMedix Inc’shares a good deal? - uspostnews.com
Why Buy Stock In CorMedix Inc (CRMD)? - Marketing Sentinel
(CRMD) On The My Stocks Page - news.stocktradersdaily.com
Investors in CorMedix (NASDAQ:CRMD) have seen decent returns of 81% over the past five years - Yahoo Finance
CorMedix Inc (CRMD)’s stock price in review: A technical analysis - uspostnews.com
RBC stays bullish on CorMedix as Q1 preliminary revenue reassures on near-term - Yahoo Finance
CorMedix expects Q1 sales above estimates, lifts H1 outlook - MSN
CorMedix reports preliminary Q1 revenue $39M, consensus $32.2M. - TipRanks
CorMedix at Needham Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
CorMedix at Needham Conference: Strategic Growth and Challenges - Investing.com
CorMedix Stock Rises After Preliminary Q1 Results Exceeds Expectations: Retail’s Elated - MSN
CRMD Soars 19.40% as CorMedix Announces Preliminary Q1 Results and Raises H1 Guidance, But Will the Momentum Continue? - RagingBull
CorMedix Inc. Raises Financial Guidance for First Half of 2025 - marketscreener.com
CorMedix Sees Q1 Net Sales of $39 Million; Boosts H1 Net Sales Guidance - MarketScreener
CorMedix reports strong preliminary Q1 revenue and EBITDA By Investing.com - Investing.com India
Cormedix Inc. Announces Preliminary First Quarter 2025 Results and Raises H1 2025 Net Sales Guidance - The Manila Times
CorMedix Logs Q1 Prel. Revenue Of $39 Mln - Nasdaq
CorMedix reports strong preliminary Q1 revenue and EBITDA - Investing.com
CorMedix Smashes Expectations: $39M Q1 Revenue and Massive Guidance Boost Signals Growth Acceleration - Stock Titan
CorMedix Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference - The Manila Times
CorMedix CEO Sets Stage for Strategic Updates at Elite Needham Healthcare Conference - Stock Titan
CorMedix Inc. (NASDAQ:CRMD) Q4 2024 Earnings Call Transcript - Insider Monkey
CorMedix Inc. Reports Record Q4 Earnings and Growth - TipRanks
CorMedix: A Fair-Priced Biotech Company With A Bright Future - Seeking Alpha
CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is Investigating CorMedix Inc. on Behalf of ... - Bluefield Daily Telegraph
Institutions along with individual investors who hold considerable shares inCorMedix Inc. (NASDAQ:CRMD) come under pressure; lose 35% of holdings value - Yahoo Finance
CorMedix targets $50M-$60M revenue for H1 2025 with DefenCath growth - MSN
CorMedix Inc.'s (NASDAQ:CRMD) 35% loss last week hit both individual investors who own 56% as well as institutions - simplywall.st
Lost Money on CorMedix Inc.(CRMD)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire
Kirby McInerney LLP Announces Investigation Against CorMedix Inc. (CRMD) on Behalf of Investors - GlobeNewswire
The Hidden Risks Behind CorMedix's First Profitable Quarter (NASDAQ:CRMD) - Seeking Alpha
CorMedix Inc (NASDAQ:CRMD) Order Delay - FXDailyReport.Com
Long Term Trading Analysis for (CRMD) - news.stocktradersdaily.com
CorMedix Inc (CRMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.27%
0.30%
자본화:
|
볼륨(24시간):